Aortic valve sizing: comparing CT scan measurements with measurements taken during surgery for people having surgical aortic valve replacement
Official title: Intraoperative Assessment Versus Preoperative Multidetector Computed Tomography (MDCT) for Aortic Valve Annular Sizing in Surgical Aortic Valve Replacement (SAVR)"
Run by Maria Cecilia Hospital · NCT07125469 · Data updated 2026-11-12
This will see if CT scan measurements match the aortic valve sizes surgeons measure during surgical aortic valve replacement in adults with severe aortic stenosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 82 (estimated) |
| Sponsor | Maria Cecilia Hospital Academic / other |
| Locations | 1 site (Cotignola, Ravenna) |
| Status | Recruiting |
| Started | June 25, 2025 |
| Main results expected | December 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT07125469 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) with isolated severe aortic stenosis who are candidates for surgical aortic valve replacement under current 2023 ESC/EACTS guidelines and can provide informed consent.
✕Probably not a fit
Patients with bicuspid aortic valves, moderate-to-severe aortic regurgitation, multivalvular disease, redo SAVR, ascending aorta aneurysm or root enlargement, or severe kidney disease (eGFR <30) are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center interventional protocol compares aortic annulus measurements from preoperative CT scans with intraoperative measurements taken using standard surgical sizing tools in adults undergoing SAVR for isolated severe aortic stenosis. CT-derived dimensions will also be used to propose theoretical sizes for two types of TAVR prostheses to examine how imaging-based sizing aligns with surgical practice. Eligible patients meet 2023 ESC/EACTS criteria for SAVR, while those with bicuspid valves, significant regurgitation, multivalvular disease, prior valve surgery, aortic root/ascending aneurysm, or severe renal dysfunction are excluded. The study quantifies differences between modalities and looks for factors linked to sizing mismatch.
Why it matters
Potential benefit: If successful, this could improve preoperative valve sizing and reduce mismatches between planned and implanted prostheses, helping surgeons choose the right valve size.
How similar studies have gone: Previous comparisons of CT-based sizing with intraoperative and TAVR sizing have shown CT can be accurate but also report discrepancies, so applying these comparisons specifically to SAVR remains only partly explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patient age 18 years or older All patients with isolated severe Aortic Stenosis (AS) considered eligible for Surgical Aortic Valve Replacement (SAVR) according to the current 2023 European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) guidelines for management of Valvular Heart Disease (reference 8) will be enrolled. Patient is willing to comply with study procedures and is available to return to the center for follow-up visits. Informed consent documentation signed and dated confirming that the patient has been adequately informed of all aspects related to his/her participation in the clinical study and is willing to participate. Exclusion Criteria: Bicuspid aortic valve anatomy Moderate to severe aortic valve regurgitation Multivalvular disease Redo Surgical Aortic Valve Replacement Ascending aorta aneurysm Aortic root enlargement Chronic Kidney Disease with estimated Glomerular Filtration Rate less than 30 milliliters per minute Body Mass Index greater than 30 kilograms per square meter Inadequate Multidetector Computed Tomography images
Where it's running
-
Maria Cecilia Hospital
Cotignola, Ravenna, Italy Recruiting
Study contacts
- Principal investigator: Fausto Castriota — Maria Cecilia Hospital
- Study coordinator: Elena Tenti
- Email: etenti@gvmnet.it
- Phone: +39 0545217031
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hydra THV Transfemoral Valve Implantation in Severe Aortic Stenosis
This registry tests how safely and effectively the Hydra THV works when implanted through the femoral artery in adults with severe symptomatic aortic stenosis.
-
Heart sound signals to detect valve and artery disease early
This observational study tests whether a new digital stethoscope-like device can pick up heart sound patterns to detect valvular or coronary artery disease earlier in people who are already getting heart imaging.
-
Pulmonary Vascular Disease in Valvular Heart Disease: How Valve Procedures Affect Blood Flow
This study tests how blood flow in the lungs changes in adults with left-sided valve disease who are having valve surgery and looks to see if patterns can predict reversibility of tricuspid regurgitation and right heart dysfunction.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
MMVD: A Multicenter Registry to Understand Multiple and Mixed Valvular Heart Disease
This study tests how common MMVD is, what imaging and management practices are used, and what factors influence outcomes in adults with two or more valve issues.
-
Screening for valvular heart disease with a single-lead ECG
This project will test whether a one-minute single-lead ECG can detect valve problems in adults by comparing ECG recordings to echocardiogram results.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.